Ericsson Powers Global Health Innovation Network in Singapore
The National University Health System (NUHS) and Sahlgrenska University Hospital have partnered with AstraZeneca, Ericsson, and Business Sweden to establish the Global Health Innovation Network (GHIN), aimed at advancing global healthcare innovation.
The partnership was formalized through a Memorandum of Understanding (MoU) signed at the Singapore-Sweden Royal Business Forum. The signing was witnessed by State Secretary for Healthcare, Ms. Miriam Söderström, and Singapore’s Permanent Secretary for Policy and Development, Ms. Lai Wei Lin, with Singapore’s Minister for Health, Mr. Ong Ye Kung, in attendance.
GHIN will focus on identifying, implementing, and scaling health innovations in screening, diagnosis, and monitoring. It seeks to address the global challenge of actualizing innovative technologies in healthcare to enhance efficiency and outcomes. This initiative is the first under the healthcare innovation collaboration MoU signed by Singapore and Sweden during the same event.
The GHIN will integrate expertise from healthcare, pharmaceutical, and communication industries. NUHS and Sahlgrenska University Hospital will provide clinical experience, hospital resources, and mentoring support, leveraging their collective knowledge to test, implement, and scale novel healthcare technologies. AstraZeneca, Ericsson, and Business Sweden will contribute with technological support, innovation platforms, and project management expertise, respectively.
GHIN is designed as an open innovation ecosystem, encouraging collaborations with Swedish, Singaporean, and international stakeholders. The founding members aim to expand partnerships in the coming years, amplifying efforts to develop and scale effective global healthcare solutions.
Dr. Boubou Hallberg, CEO, Sahlgrenska University Hospital
Implementing the newest technologies and leveraging opportunities from research and innovation worldwide strengthens global healthcare. This collaboration also helps new treatments reach patients from all over the world faster.
Adjunct Professor Jason Phua, Deputy Chief Executive (Clinical Transformation), NUHS
As an academic health system, we will bring together expertise in clinical care, research, and education to support this collaboration. When we combine our strengths with the unique capabilities of our partners, we can contribute meaningfully to the advancement of patient care and the improvement of global health.
Kim Suyeon, Country President, AstraZeneca Singapore
We are really excited to come onboard this meaningful collaboration, leveraging AstraZeneca’s global healthcare innovation platform, A.Catalyst Network. As part of a broader network of ecosystem stakeholders, our role as a founding industry partner is to support the scouting of innovative solutions towards solving identified problem statements across the healthcare systems, potentially helping to scale effectively implemented solutions to other markets via our network.
Daniel Ode, Head of Ericsson Singapore, Philippines, and Brunei
High performance connectivity based on 5G will transform healthcare. By joining the GHIN as a founding partner, we will fuel innovation in healthcare services based on our ability to blend technological innovation with medical knowledge. With 5G, we can extend the reach of the healthcare system to many people for whom healthcare access and treatment is a challenge.
Representative from Business Sweden
I am proud that Business Sweden can support GHIN and hope that we can enable a strong and productive collaboration. We will focus on expanding its reach by bringing in new partners and aim for faster adoption and larger scaling of healthcare innovations worldwide.
link
